The latest clinical breakthroughs, practice management updates, and national advocacy alerts directly from the American Academy of Ophthalmology.
Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study)
Both vascular endothelial growth factor inhibitors and steroids given intravitreally have demonstrated superior visual acuity (VA) benefits to laser and/or sham for center-involving diabetic macular edema (DME).1
We extend our deepest gratitude to our Platinum, Gold, and Silver partners. Your generous support fuels our mission to advance medical education, advocate for patient safety, and foster breakthrough innovations across West Virginia.